1. Home
  2. DVA vs RBC Comparison

DVA vs RBC Comparison

Compare DVA & RBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DVA
  • RBC
  • Stock Information
  • Founded
  • DVA 1994
  • RBC 1919
  • Country
  • DVA United States
  • RBC United States
  • Employees
  • DVA N/A
  • RBC N/A
  • Industry
  • DVA Misc Health and Biotechnology Services
  • RBC Metal Fabrications
  • Sector
  • DVA Health Care
  • RBC Industrials
  • Exchange
  • DVA Nasdaq
  • RBC Nasdaq
  • Market Cap
  • DVA 10.9B
  • RBC 9.7B
  • IPO Year
  • DVA 1995
  • RBC 2005
  • Fundamental
  • Price
  • DVA $136.18
  • RBC $365.90
  • Analyst Decision
  • DVA Hold
  • RBC Buy
  • Analyst Count
  • DVA 4
  • RBC 8
  • Target Price
  • DVA $157.00
  • RBC $366.83
  • AVG Volume (30 Days)
  • DVA 828.5K
  • RBC 160.2K
  • Earning Date
  • DVA 05-12-2025
  • RBC 05-16-2025
  • Dividend Yield
  • DVA N/A
  • RBC N/A
  • EPS Growth
  • DVA 14.90
  • RBC 20.13
  • EPS
  • DVA 10.11
  • RBC 7.70
  • Revenue
  • DVA $12,968,524,000.00
  • RBC $1,636,300,000.00
  • Revenue This Year
  • DVA $6.00
  • RBC $9.33
  • Revenue Next Year
  • DVA $3.66
  • RBC $7.43
  • P/E Ratio
  • DVA $13.48
  • RBC $47.52
  • Revenue Growth
  • DVA 5.11
  • RBC 4.87
  • 52 Week Low
  • DVA $131.76
  • RBC $260.53
  • 52 Week High
  • DVA $179.60
  • RBC $380.49
  • Technical
  • Relative Strength Index (RSI)
  • DVA 37.73
  • RBC 59.29
  • Support Level
  • DVA $136.50
  • RBC $351.19
  • Resistance Level
  • DVA $140.42
  • RBC $376.12
  • Average True Range (ATR)
  • DVA 3.66
  • RBC 9.95
  • MACD
  • DVA -0.59
  • RBC -0.78
  • Stochastic Oscillator
  • DVA 11.71
  • RBC 51.20

About DVA DaVita Inc.

DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.

About RBC RBC Bearings Incorporated

RBC Bearings Inc is an international manufacturer and marketer of highly engineered precision bearings, components and essential systems for the industrial, defense and aerospace industries. The offering includes plain bearings, roller bearings, ball bearings, and engineered products. The end market is the United States of America. The company has two reportable segments: Aerospace Defense segment represents the end markets for the company's highly engineered bearings and precision components used in commercial aerospace, defense aerospace, and sea and ground defense applications; and Industrial segment represents the end markets for the company's engineered bearings and precision components used in various industrial applications. It derives maximum revenue from Industrial Segment.

Share on Social Networks: